Published in:
01-12-2012 | Letter to the Editor
Acute, generalised but transient muscle cramping and weakness shortly after first oxaliplatin infusion
Authors:
Elisabeth Krexner, Anika Stickler, Christian Prainer, Josef Finsterer
Published in:
Medical Oncology
|
Issue 5/2012
Login to get access
Excerpt
Oxaliplatin is a platinum derivative, which is increasingly applied in chemotherapy of various malignancies, most frequently gastrointestinal malignancies [
1]. Oxaliplatin may cause a number of adverse reactions, frequently neurological in nature (neurotoxicity), which may be acute or chronic [
1‐
3]. Acute neurotoxicity manifests as sensory disturbances of the hands, feet, pharynx or larynx, or throat or jaw tightness, triggered or exacerbated by cold [
1,
3,
4]. More rare acute neurological side effects include blepharoptosis or neuromyotonia [
1,
5]. Repetitive nerve stimulation may show an abnormal decremental response and needle EMG neuromyotonic discharges [
6]. Neurotoxicity from oxaliplatin is usually transient and reversible with complete recovery [
7]. Chronic neurotoxicity of oxaliplatin includes sensory neuropathy, hyperexcitability syndrome, muscle cramps, dysarthria, ptosis, or visual field defects [
4]. …